RISK BASED INSPECTION [SCHEDULE M -POINT (15.1-15.5)]
![RISK BASED INSPECTION [SCHEDULE M -POINT (15.1-15.5)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-15.1-15.5-768x1087.jpg)
Risk-Based Inspection (RBI) is a methodology that rates manufacturing sites by the risk they may pose to patients and product quality, and then determines the frequency, depth and scope of GMP inspection accordingly. CDSCO For Schedule M points 15.1–15.5 (Sanitation…





![RISK BASED INSPECTION [SCHEDULE M & WHO TRS 986-POINT (14.16-14.20)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-WHO-TRS-986-14.16-14.20-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (14.10-14.15)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-14.10-14.15-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (14.6-14.9)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-14.6-14.9-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (14.3-14.5)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-14.3-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (14.2)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-14.2-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (14.1)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-14.1-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M & WHO TRS 986-POINT (13.6-13.10)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-WHO-TRS-986-13.6-13.10-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M & WHO TRS 986-POINT (13.2-13.5)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-WHO-TRS-986-13.2-13.5-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (13.1)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-13.1-768x1086.jpg)